Oxidative pathways as a drug target for the treatment of autism
about
Minocycline: therapeutic potential in psychiatryAdvanced pharmacotherapy evidenced by pathogenesis of autism spectrum disorder.Aspirin: a review of its neurobiological properties and therapeutic potential for mental illnessDi-(2-ethylhexyl) phthalate and autism spectrum disordersErythrocyte shape abnormalities, membrane oxidative damage, and β-actin alterations: an unrecognized triad in classical autism.Gene-environment interactions and epigenetic pathways in autism: the importance of one-carbon metabolism.Autism biomarkers: challenges, pitfalls and possibilities.A randomised, double blind, placebo-controlled trial of a fixed dose of N-acetyl cysteine in children with autistic disorder.Downregulating the canonical Wnt/β-catenin signaling pathway attenuates the susceptibility to autism-like phenotypes by decreasing oxidative stress.Adolescent GBR12909 exposure induces oxidative stress, disrupts parvalbumin-positive interneurons, and leads to hyperactivity and impulsivity in adult mice.Nuclear factor kappa B may increase insight into the management of neuroinflammation and excitotoxicity in autism.
P2860
Q22241418-9D6B9358-050D-4579-9F11-A4B12DDCFC46Q33618938-B85D8A45-5FAD-4485-9728-332BAE0B02BBQ34626598-776909CA-2E62-400D-A0CD-FBFB898551E9Q35998061-CC19CE5C-C15E-4637-B533-28C6459EE464Q37433276-BE5E3D6B-ABC6-4303-AA81-A8827F111AEBQ38112675-576E2E66-0237-45AB-BCFB-866E07017771Q38246388-B7A78BF5-7F92-479E-96AF-5885D665A327Q39674410-73E3EFCF-E94F-4095-8FFD-D61E4151CECBQ45414556-DF990A5B-EA01-4F04-BC5A-436921F653E0Q46508064-9C7C8664-DDD8-485A-892C-69E41F68607BQ50310961-D3B77ABD-3029-42C5-BCF8-1210D46FA46D
P2860
Oxidative pathways as a drug target for the treatment of autism
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Oxidative pathways as a drug target for the treatment of autism
@ast
Oxidative pathways as a drug target for the treatment of autism
@en
Oxidative pathways as a drug target for the treatment of autism
@nl
type
label
Oxidative pathways as a drug target for the treatment of autism
@ast
Oxidative pathways as a drug target for the treatment of autism
@en
Oxidative pathways as a drug target for the treatment of autism
@nl
prefLabel
Oxidative pathways as a drug target for the treatment of autism
@ast
Oxidative pathways as a drug target for the treatment of autism
@en
Oxidative pathways as a drug target for the treatment of autism
@nl
P2093
P2860
P50
P1476
Oxidative pathways as a drug target for the treatment of autism
@en
P2093
Kristi-Ann Villagonzalo
Olivia Dean
Seetal Dodd
P2860
P304
P356
10.1517/14728222.2010.528394
P407
P577
2010-12-01T00:00:00Z